US STRATEGY – ROLLING OVER

The S&P rolled over on Wednesday, with all of the major indexes finishing down more than 1% on the session.  Tuesday’s euphoria over the election in Massachusetts was quickly overcome by the potential for Congressional gridlock on a number of important issues.  Overall the volume was still light, but was up 1.9% day-to-day; breadth was the worst it’s been all year. 

 

The Hedgeye RISK Management sector models saw a breakdown yesterday in two sectors – XLY and XLU – both broke TRADE. All nine sectors declined yesterday and all nine are positive on TREND. 

 

On the MACRO front, the “CHINESE OX IN A BOX” and liquidity concerns were on the front burner as the focus was on Beijing's efforts to curb new bank lending.  Not surprisingly, this dynamic weighed on the RECOVERY trade as the Dollar Index continues to trade higher.  Of the three worst performing sectors two are leveraged to the RECOVERY TRADE - Materials (XLB) and Energy (XLE).  

 

The XLE and XLB were also hit by the strength in our “BUCK BREAKOUT” theme, which underpinned the safe haven status (i.e. better fiscal outlook now that Democrats have lost in Massachusetts and heightened risk aversion with the VIX up +6.1% on the day yesterday.  Precious metals and industrial stocks were among the biggest decliners in the XLB, while higher-beta coal and oil services stocks were underperformers in the XLE sector.  On Wednesday, crude closed down 1.9% to $77.74 a barrel.

 

Also on the MACRO front the MBA mortgage applications slowed to 9.1% from 14.3% and housing starts declined 4% from 8.9% last month.  On the positive side building permits were 653,000 vs. 584,000 last month. 

 

Also taking center stage on the downside was Technology (XLK).  The XLK underperformed yesterday despite the Q4 earnings beat from IBM. There was weakness in the software group today, with the S&P Software Index declining 1.4%, while the Semis held up better than the broader XLK. 

 

The best performing sector yesterday was the Financials (XLF), down only 0.3% on the day.  Within the XLF the banking group bucked the broader market selloff today with the BKX up 1.4% with the Trust names (STT, NTRS and BK) trading higher following their Q4 earnings results. Regional banking stocks are also performing wells after their Q4 earnings reports.

 

As we look at today’s set up the range for the S&P 500 is at 20 points or 0.43% (1,133) downside and 1.05% (1,150) upside.  At the time of writing the major market futures are trading down on the day.  

 

Copper imports by China, climbed for a second month in December on rising demand.  Despite this news Copper traded down 2.67% yesterday and is flattish in early trading today.  The Hedgeye Risk Management Quant models have the following levels for COPPER – buy Trade (3.32) and Sell Trade (3.46).

 

In early trading today Gold is declining for a second day, after falling 2.4% yesterday; the biggest decline since December 17, 2009.  The Hedgeye Risk Management models have the following levels for GOLD – buy Trade (1,101) and Sell Trade (1,134).

 

Yesterday crude traded down by 1.9%, and is trading slightly lower in early trading today.  The strength in the Dollar and increased inventories are putting pressure on oil.  The Hedgeye Risk Management models have the following levels for OIL – buy Trade (76.94) and Sell Trade (80.49).

                                                   

Howard Penney

Managing Director

 

US STRATEGY – ROLLING OVER - sp1

 

US STRATEGY – ROLLING OVER - usdx2

 

US STRATEGY – ROLLING OVER - vix3

 

US STRATEGY – ROLLING OVER - oil4

 

US STRATEGY – ROLLING OVER - gold5

 

US STRATEGY – ROLLING OVER - copper6

 


GOLD: A Deep Dive on What’s Next with a Top Commodities Strategist

“If you saved in gold over the past 20 to 25 years rather than any currency anywhere in the world, gold has outperformed all these currencies,” says Stefan Wieler, Vice President of Goldmoney in this edition of Real Conversations.

read more

Exact Sciences Up +24% This Week... What's Next? | $EXAS

We remain long Exact Sciences in the Hedgeye Healthcare Position Monitor.

read more

Inside the Atlanta Fed's Flawed GDP Tracker

"The Atlanta Fed’s GDPNowcast model, while useful at amalgamating investor consensus on one singular GDP estimate for any given quarter, is certainly not the end-all-be-all of forecasting U.S. GDP," writes Hedgeye Senior Macro analyst Darius Dale.

read more

Cartoon of the Day: Acrophobia

"Most people who are making a ton of money right now are focused on growth companies seeing accelerations," Hedgeye CEO Keith McCullough wrote in today's Early Look. "That’s what happens in Quad 1."

read more

People's Bank of China Spins China’s Bad-Loan Data

PBoC Deputy Governor Yi says China's non-performing loan problem has “pretty much stabilized." "Yi is spinning. China’s bad-debt problem remains serious," write Benn Steil and Emma Smith, Council on Foreign Relations.

read more

UnderArmour: 'I Am Much More Bearish Than I Was 3 Hours Ago'

“The consumer has a short memory.” Yes, Plank actually said this," writes Hedgeye Retail analyst Brian McGough. "Last time I heard such arrogance was Ron Johnson."

read more

Buffalo Wild Wings: Complacency & Lack of Leadership (by Howard Penney)

"Buffalo Wild Wings has been plagued by complacency and a continued lack of adequate leadership," writes Hedgeye Restaurants analyst Howard Penney.

read more

Todd Jordan on Las Vegas Sands Earnings

"The quarter actually beat lowered expectations. Overall, the mass segment performed well although base mass lagging is a concern," writes Hedgeye Gaming, Lodging & Leisure analyst Todd Jordan on Las Vegas Sands.

read more

An Update on Defense Spending by Lt. Gen Emo Gardner

"Congress' FY17 omnibus appropriation will fully fund the Pentagon's original budget request plus $15B of its $30B supplemental request," writes Hedgeye Potomac Defense Policy analyst Lt. Gen Emerson "Emo" Gardner USMC Ret.

read more

Got Process? Zero Hedge Sells Fear, Not Truth

Fear sells. Always has. Look no further than Zero Hedge.

read more

REPLAY: Review of $EXAS Earnings Call (A Hedgeye Best Idea Long)

Our Healthcare Team made a monster call to be long EXAS - hear their updated thoughts.

read more

Capital Brief: 5 Things to Watch Right Now In Washington

Here's a quick look at some key issues investors should keep an eye on from Hedgeye's JT Taylor and our team of Washington Policy analysts in D.C.

read more